HERFX
Price
$10.18
Change
+$0.01 (+0.10%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

HERFX vs RNWFX

Header iconHERFX vs RNWFX Comparison
Open Charts HERFX vs RNWFXBanner chart's image
Hartford Emerging Markets Equity F
Price$10.18
Change+$0.01 (+0.10%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
HERFX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HERFX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HERFX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. HERFX (360M). HERFX pays higher dividends than RNWFX: HERFX (3.86) vs RNWFX (1.51). HERFX was incepted earlier than RNWFX: HERFX (8 years) vs RNWFX (23 years). HERFX is a more actively managed with annual turnover of: 93.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than HERFX: RNWFX (250) vs HERFX (1000000). HERFX annual gain was more profitable for investors over the last year : 17.42 vs. RNWFX (5.86). HERFX return over 5 years is better than : 21.95 vs. RNWFX (14.39).
HERFXRNWFXHERFX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD15.0284.549330%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets360M62.2B1%
Annual Yield % from dividends3.861.51256%
Returns for 1 year17.425.86297%
Returns for 3 years7.11-5.10-139%
Returns for 5 years21.9514.39153%
Returns for 10 yearsN/A42.67-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics